TGA approval of the STI kit in the first half of next year might help things along if it brings in more Australian sales because the potential market here is large due to it being used for screening purposes. Exact Sciences in the US have a molecular screening test for colon cancer and their MC is >$10 bill.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
GSS
genetic signatures limited
Add to My Watchlist
6.33%
!
42.0¢

TGA approval of the STI kit in the first half of next year might...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $95.39M |
Open | High | Low | Value | Volume |
39.8¢ | 42.0¢ | 39.5¢ | $67.52K | 167.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 22000 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 21621 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 22000 | 0.390 |
3 | 29354 | 0.370 |
1 | 10000 | 0.365 |
2 | 7013 | 0.360 |
1 | 40000 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 21621 | 1 |
0.455 | 5000 | 1 |
0.490 | 13000 | 1 |
0.500 | 2138 | 1 |
0.510 | 5000 | 1 |
Last trade - 15.57pm 21/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |